Generate a tailored SOP for Dr. Christopher Azzoli. Improve your application with a focused, well-structured draft.
Christopher Azzoli is an Associate Professor of Translational Medicine and a medical oncologist specializing in the treatment of lung cancer, mesothelioma, and thymoma. He previously served on the faculty at Memorial Sloan-Kettering Cancer Center in New York and Massachusetts General Hospital Cancer Center in Boston. In 2018, he became the Director of Thoracic Oncology at Lifespan Cancer Institute in Providence, Rhode Island. His clinical research primarily focuses on conducting phase 1b-2 clinical trials for new drugs aimed at treating patients with lung cancer. He has a particular interest in developing drugs that can overcome both de novo and acquired resistance to anti-PD1 immune checkpoint blockade therapies. Additionally, he is working on developing blood tests to detect T-cell mediated anti-cancer immune activity in patients, contributing significant advancements to the field of oncology.
Lifespan Cancer Institute • Providence, RI
Oversees thoracic oncology department, conducting clinical trials and research.
Department: Department of Economics